A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers

Transfusion

Volumn 37, Issue 2, 1997, Pages 182-187

  Liles, W C ^a,b   Huang, J E ^a,b   Llewellyn, C ^a,b   SenGupta, D ^a,b   Price, T H ^a,b,c   Dale, D C ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTHRALGIA; ARTICLE; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTE TRANSFUSION; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MYALGIA; NEUTROPHILIA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031049553     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37297203521.x     Document Type: Article

References (49)

1. Malech HL, Gallin JI. Current concepts: immunology. Neutrophils in human diseases. N Engl J Med 1987;317:687-94.
2. Lehrer RI, Ganz T, Selsted ME, et al. Neutrophils and host defense (clinical conference). Ann Intern Med 1988;109:127-42.
3. Liles WC, Dale DC. Current approach to the management of neutropenia. J Intensive Care Med (in press).
4. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990;161:381-96.
5. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
6. Strauss RG. Therapeutic granulocyte transfusions in 1993 (editorial). Blood 1993;81:1675-8.
7. Groopman JE, Molina JM, Scadden DT. Hematopoietic growth factors. Biology and clinical applications. N Engl J Med 1989;321:1449-59.
8. Weisbart RH, Golde DW. Physiology of granulocyte and macrophage colony-stimulating factors in host defense. Hematol Oncol Clin North Am 1989;3:401-9.
9. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791-808.
10. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med 1992;327:28-35.
11. Lieschke GJ, Burgess AW. Granulocyte colony stimulating factor and granulocyte-macrophage colony-stimulating factor (2). N Engl J Med 1992;327:99-106.
12. Dale DC, Liles WC, Summer WR, Nelson S. Review: granulocyte colony-stimulating factor - role and relationships in infectious diseases. J Infect Dis 1995;172:1061-75.
13. Gasson JC. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 1991;77:1131-45.
14. Crawford J, Ozer J, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-70.
15. Gisselbrecht C, Prentice HG, Bacigalupo A, et al. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 1994;343:696-700.
16. Gabrilove JL, Jakubowski A, Scher H, et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.
17. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993;81:2496-502.
18. Maher DW, Lieschke GJ, Green M, et al. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med 1994;121:492-501.
19. Nemunaitis J, Rabinowe SN, Singer JW, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991;324:1773-8.
20. De Vries EG, Biesma B, Willemse PH, et al. A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma. Cancer Res 1991;51:116-22.
21. Gerhartz HH, Engelhard M, Meusers P, et al. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 1993;82:2329-39.
22. American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol 1994;12:2471-508.
23. Schiffer CA. Granulocyte transfusions: an overlooked therapeutic modality. Transfus Med Rev 1990;4:2-7.
24. Freireich EJ. White cell transfusions born again. Leuk Lymphoma 1994;11(Suppl 2):161-5.
25. Dale DC, Fauci AS, Guerry D IV, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest 1975;56:808-13.
26. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method, donor corticosteroid treatment, and short-term storage. Blood 1979;54:977-86.
27. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
28. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
29. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 1977;296:706-11.
30. Graw RG Jr, Herzig G, Perry S, Henderson ES. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 1972;287:367-71.
31. Fortuny IE, Bloomfield CD, Hadlock DC, et al. Granulocyte transfusion: A controlled study in patients with acute non-lymphocytic leukemia. Transfusion 1975;15:548-58.
32. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med 1975;292:761-6.
33. McCullough J, Weiblen BJ, Deinard AR, et al. In vitro function and post-transfusion survival of granulocytes collected by continuous-flow centrifugation and by filtration leukapheresis. Blood 1976;48:315-26.
34. Hammerschmidt DE, Craddock PR, McCullough J, et al. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis. Blood 1978;51:721-30.
35. Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method, donor corticosteroid treatment, and short-term storage. Blood 1979;54:977-86.
36. Menitove JE, Abrams RA. Granulocyte transfusions in neutropenic patients. Crit Rev Oncol Hematol 1987;7:89-113.
37. Strauss RG, Rohret PA, Randels MJ, Winegarden D. Granulocyte collection. J Clin Apheresis 1991;6:241-3.
38. Herzig RH, Herzig GP, Graw RG Jr, et al. Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study. N Engl J Med 1977;296:701-5.
39. Vogler WR, Winton EF. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 1977;63:548-55.
40. Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med 1982;97:509-15.
41. Leitman SF, Yu M, Lekstrom J. Pair-controlled study of granulocyte colony stimulating factor (G-CSF) plus dexamethasone (Dexa) for granulocytapheresis donors (abstract). Transfusion 1995;35(Suppl):53S.
42. Whyte MK, Meagher LC, MacDermot J, Haslett C. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol 1993;150:5124-34.
43. Colotta F, Re F, Polentarutti N, et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
44. Cox G, Gauldie J, Jordana M. Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992;7:507-13.
45. Rex JH, Bhalla SC, Cohen DM, et al. Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon-γ and granulocyte-colony-stimulating factor. Transfusion 1995;35:605-11.
46. Adachi S, Kubota M, Lin YW, et al. In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro. Eur J Haematol 1994;53:129-34.
47. Liles WC, Rodger ER, Dale DC. In vivo administration of granulocyte colony-stimulating factor to normal human subjects: priming of the respiratory burst and inhibition of apoptosis in neutrophils (abstract). Blood 1994;84(Suppl 1):371a.
48. Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181-8.
49. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995;154:4719-25.